TAS::75 0849::TAS DEVELOPMENT AND MANUFACTURE OF ORAL AND TOOPICAL DOSAGE FORMS

Information

• Research Project
• 8605136

• ApplicationId

  8605136

• Core Project Number

  N02CM000000

• Full Project Number

  261201000023C-7-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  7/1/2010 - 14 years ago

• Project End Date

  6/30/2015 - 9 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2013

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• IRISYS, INC.

One of the essential parts of the mission of The Developmental Therapeutic Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) is involved in discovery and development of new therapeutic agents and the manufacture and supply of dosage forms to support human clinical trials under the NCI sponsorship or through investigator initiated INDs. Molecules for development enter the system under various mechanisms such as NCI Experimental Therapeutics Program (NExT) or ¿Joint Development¿ programs. The contract provides the NCI with pharmaceutical development and production of oral and topical dosage forms for use in clinical trials, advanced Pharmacology, and IND directed Toxicology testing.

IC Name

• Activity

  N02

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  283206

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:283206\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  IRISYS, INC.

• Organization Department

• Organization DUNS

  079682716

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  92121

• Organization District

  UNITED STATES